A scene of the Novo Nordsk logo at the company's office in Bagfaird, on the outskirts of Copenhagen, Denmark, March 8, 2024.
Tom Little Reuters
shares Novo Nordsk The shares of the Giant Danish pharmaceutical company jumped on Friday after the Danish Drug Administration announced positive results at an early stage of the ammearine for obesity, which is used once a week.
The experiment showed an average weight of weight by 22% in patients with obesity and weight gain after 36 weeks.
The shares the last time increased by 9.5 % at 11:02 am London time.
This is an advanced story. Please check again for updates.
